Nanotechnology: A new frontier in the fight against cancer

Relevant News

By Dr Yiota Gregoriou*

On World Cancer Research Day, we reflect on the groundbreaking advancements in cancer research, with nanotechnology standing at the forefront of this revolution.

From Richard Feynman’s far-reaching ideas in the 1950s to today’s “smart” nanovehicles, nanotechnology has progressed into a promising era in the battle against cancer.

The emergence of nanotechnology has become a fundamental pillar in cancer research, bringing hope for a new era in cancer diagnosis and treatment. The word “nano,” derived from the Greek word for dwarf, refers to a scale so small that it is hard to imagine. A nanometer is a million times smaller than a millimetre, which is the smallest measure on a standard ruler. If this is still hard to picture, imagine shrinking yourself down 100,000 times. At that scale, you would be about the size of a red blood cell. Now, if the red blood cell were as big as a football field, a nanometer by comparison would be as small as a tiny piece of marble.

At this nanoscale, drug delivery vehicles offer tremendous opportunities in cancer treatment. These tiny machines come in different sizes and shapes and are engineered to carry therapeutics precisely to tumours. This precise targeting not only enhances the therapeutic potential of the treatment but also minimizes the side effects often associated with traditional methods.

Nanotechnology gained public attention during the COVID-19 pandemic, using lipid nanoparticles in the development of mRNA vaccines. However, nanotechnology dates back much further. In 1959, physicist Richard Feynman gave a talk at Caltech University titled “There’s Plenty of Room at the Bottom,” inspiring the early vision for the field. Feynman proposed a future where scientists could manipulate matter at the atomic scale, engineering molecular machines or “nanorobots.” Nowadays, “nanorobots” capable of delivering drugs to cancer cells are becoming a reality, allowing for precise treatment of diseased tissue. Precise engineering enables nanovehicles to navigate through the body, find and recognize tumour cells, and release their therapeutic cargo directly to the source. Even more remarkable are the latest “smart” nanoparticles, which release their cargo only in response to biological triggers such as pH and temperature changes. Some not only deliver drugs but can also destroy cancer cells through processes like photothermal therapy, which uses heat to eradicate cancer.

Beyond drug delivery, or even in combination with it, such nanostructures are utilized to carry diagnostic payloads, providing surgeons with tools to precisely remove tumors. Additionally, they enhance the visibility of cancer cells in traditional imaging techniques, such as MRI or CT, allowing for earlier detection and more precise diagnosis. Such advanced systems have already been tested in clinical trials, and some have been FDA-approved, raising hope in the fight against cancer.

Among the many promising developments is a nanovehicle developed at the University of Cyprus by Dr Yiota Gregoriou, Ms Gregoria Gregoriou, and Emeritus Prof. Andreas Constantinou. This innovative technology, recently patented by the University, shows great promise in targeting triple-negative breast cancer (TNBC), a challenging type with poor prognosis. TNBC is tricky to treat as it lacks common receptors often exploited for the targeting of “magic bullet” drugs to the cancerous tissue. However, this nanoinvention can enter TNBC cells and boost the treatment while remarkably avoiding normal cells, potentially minimizing the side effects often associated with chemotherapy.

As we mark World Cancer Research Day, we acknowledge and celebrate the progress made in cancer research, while also honouring the efforts of dedicated researchers in the fight against cancer. At the biobank.cy Center of Excellence, we are committed to advancing research through innovative nanotechnologies and striving for a future in research that would even make Feynman proud.

*Dr. Yiota Gregoriou is a Senior Scientist at the biobank.cy Center of Excellence in Biobanking and Biomedical Research at the University of Cyprus, where she previously led research efforts on generating innovative drug delivery nanoparticles in cancer.

Follow en.philenews on Google News and be the first to know all the news about Cyprus and the world.